Metastatic Crohn’s disease despite infliximab therapy

AUTOR(ES)

Campos, Sara, Coutinho, Inês, Cardoso, José Carlos, Portela, Francisco

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2017

RESUMO

Abstract Metastatic Crohn’s disease is a rare extraintestinal manifestation of Crohn’s disease. It is characterized by polymorphic skin lesions formed by non-caseating granulomas located on anatomical sites distant from the gastrointestinal tract. We report a rare case of metastatic Crohn’s disease, simultaneously displaying multiple clinically heterogeneous cutaneous lesions, in a patient with previously diagnosed Crohn’s disease in remission due to anti-TNF-α use. This case highlights the need for high clinical suspicion and early biopsy in the setting of a patient with Crohn’s disease and persistent skin lesions, even under biologic therapy. Furthermore, it reinforces the need of monitoring of the serum level of infliximab, increasing the dose in case it is low or undetectable.

Documentos Relacionados

• Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease
• Metastatic Crohn's disease.
• Case for diagnosis. Metastatic Crohn's disease
• Long-term response rates to infliximab therapy for Crohn’s disease in an outpatient cohort
• Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease